European Journal of Cancer
Volume 45, Issue 1 , Pages 90-98 , January 2009

Management and outcome of stage 3 neuroblastoma

  • Shakeel Modak

      Affiliations

    • Department of Paediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    • Corresponding Author InformationCorresponding author: Tel.: +1 212 639 7623; fax: +1 212 717 3695.
    • ,
  • Brian H. Kushner

      Affiliations

    • Department of Paediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    • Tel.: +1 212 639 6793
    • ,
  • Michael P. LaQuaglia

      Affiliations

    • Department of Surgery, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    • Tel.: +1 212 639 7002
    • ,
  • Kim Kramer

      Affiliations

    • Department of Paediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    • Tel.: +1 212 639 6410
    • ,
  • Nai-Kong V. Cheung

      Affiliations

    • Department of Paediatrics, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10065, United States
    • Tel.: +1 646 888 2313

Received 17 July 2008 ,Revised 24 August 2008 ,Accepted 25 September 2008.

  • Image Result

    Memorial Sloan-Kettering Cancer Centre (MSKCC) algorithm for management of patients with International Neuroblastoma (NB) Staging System (INSS) stage 3 NB.

    Memorial Sloan-Kettering Cancer Centre (MSKCC) algorithm for management of patients with International Neuroblastoma (NB) Staging System (INSS) stage 3 NB.

  • Image Result

    Distribution of patients with stage 3 NB.

    Distribution of patients with stage 3 NB.

  • Image Result

    Kaplan–Meier analysis for overall survival in patients with stage 3 NB: group A: patients with MYCN-non-amplified NB treated with surgical resection without chemotherapy; group B: MYCN-non-amplified N

    Kaplan–Meier analysis for overall survival in patients with stage 3 NB: group A: patients with MYCN-non-amplified NB treated with surgical resection without chemotherapy; group B: MYCN-non-amplified NB patients treated with chemotherapy at non-MSKCC institutions prior to surgical resection and group C: patients with MYCN-amplified NB.

  • Image Result
    Kaplan–Meier analysis for event-free survival in patients with stage 3 NB.

    Kaplan–Meier analysis for event-free survival in patients with stage 3 NB.

PII: S0959-8049(08)00748-X

doi: 10.1016/j.ejca.2008.09.016

European Journal of Cancer
Volume 45, Issue 1 , Pages 90-98 , January 2009

Article Tools

* Image Usage & Resolution